Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Howard

Showing results (41-50 of 265) with videos related to

Pageof 27
Sort By:
International Journal of Geriatric Psychiatry|September 6, 2014
Psychotic major depression in older people: a systematic reviewRossetos Gournellis, Panagiotis Oulis, Robert Howard
International Journal of Geriatric Psychiatry|June 20, 2006
Abuse of vulnerable people with dementia by their carers: can we identify those most at risk?Colm Cooney, Robert Howard, Brian Lawlor
The Cochrane Database of Systematic Reviews|April 17, 2009
Cannabinoids for the treatment of dementiaSarada Krishnan, Ruth Cairns, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 14, 2025
Response to letter to the editorKathy Y Liu, Stephen Senn, Robert Howard
Psychological Medicine|December 5, 2017
The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016Jean Stafford, Robert Howard, James B Kirkbride
The Journal of Experimental Biology|September 9, 2015
Tropical flatback turtle (Natator depressus) embryos are resilient to the heat of climate changeRobert Howard, Ian Bell, David A Pike
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's diseaseKathy Y Liu, Stephen Senn, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2022
How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?Kathy Y Liu, Madhav Thambisetty, Robert Howard
The Journal of Prevention of Alzheimer'S Disease|May 7, 2026
Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE<sub>4</sub> heterozygotes and non-carriersJemma Hazan, Kathy Y Liu, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2026
What should convince a clinician of disease modification in Alzheimer's disease clinical trials?Jemma Hazan, Kathy Y Liu, Robert Howard
Pageof 27

Showing results (41-50 of 265) with videos related to

Sort By:
Pageof 27
International Journal of Geriatric Psychiatry|September 6, 2014
Psychotic major depression in older people: a systematic reviewRossetos Gournellis, Panagiotis Oulis, Robert Howard
International Journal of Geriatric Psychiatry|June 20, 2006
Abuse of vulnerable people with dementia by their carers: can we identify those most at risk?Colm Cooney, Robert Howard, Brian Lawlor
The Cochrane Database of Systematic Reviews|April 17, 2009
Cannabinoids for the treatment of dementiaSarada Krishnan, Ruth Cairns, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 14, 2025
Response to letter to the editorKathy Y Liu, Stephen Senn, Robert Howard
Psychological Medicine|December 5, 2017
The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016Jean Stafford, Robert Howard, James B Kirkbride
The Journal of Experimental Biology|September 9, 2015
Tropical flatback turtle (Natator depressus) embryos are resilient to the heat of climate changeRobert Howard, Ian Bell, David A Pike
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 27, 2025
Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's diseaseKathy Y Liu, Stephen Senn, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 26, 2022
How can secondary dementia prevention trials of Alzheimer's disease be clinically meaningful?Kathy Y Liu, Madhav Thambisetty, Robert Howard
The Journal of Prevention of Alzheimer'S Disease|May 7, 2026
Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE<sub>4</sub> heterozygotes and non-carriersJemma Hazan, Kathy Y Liu, Robert Howard
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 1, 2026
What should convince a clinician of disease modification in Alzheimer's disease clinical trials?Jemma Hazan, Kathy Y Liu, Robert Howard
Pageof 27